European Union - English - EMA (European Medicines Agency)

astrazeneca ab - nirsevimab - immune sera and immunoglobulins, - beyfortus is indicated for the prevention of respiratory syncytial virus (rsv) lower respiratory tract disease in neonates and infants during their first rsv season.beyfortus should be used in accordance with official recommendations.

Canada - English - Health Canada

astrazeneca canada inc - nirsevimab - solution - 50mg - nirsevimab 50mg

Canada - English - Health Canada

astrazeneca canada inc - nirsevimab - solution - 100mg - nirsevimab 100mg